149
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Alcohol, tobacco, and illegal drug use cause considerable morbidity and mortality, but good cross-national epidemiological data are limited. This paper describes such data from the first 17 countries participating in the World Health Organization's (WHO's) World Mental Health (WMH) Survey Initiative.

          Methods and Findings

          Household surveys with a combined sample size of 85,052 were carried out in the Americas (Colombia, Mexico, United States), Europe (Belgium, France, Germany, Italy, Netherlands, Spain, Ukraine), Middle East and Africa (Israel, Lebanon, Nigeria, South Africa), Asia (Japan, People's Republic of China), and Oceania (New Zealand). The WHO Composite International Diagnostic Interview (CIDI) was used to assess the prevalence and correlates of a wide variety of mental and substance disorders. This paper focuses on lifetime use and age of initiation of tobacco, alcohol, cannabis, and cocaine. Alcohol had been used by most in the Americas, Europe, Japan, and New Zealand, with smaller proportions in the Middle East, Africa, and China. Cannabis use in the US and New Zealand (both 42%) was far higher than in any other country. The US was also an outlier in cocaine use (16%). Males were more likely than females to have used drugs; and a sex–cohort interaction was observed, whereby not only were younger cohorts more likely to use all drugs, but the male–female gap was closing in more recent cohorts. The period of risk for drug initiation also appears to be lengthening longer into adulthood among more recent cohorts. Associations with sociodemographic variables were consistent across countries, as were the curves of incidence of lifetime use.

          Conclusions

          Globally, drug use is not distributed evenly and is not simply related to drug policy, since countries with stringent user-level illegal drug policies did not have lower levels of use than countries with liberal ones. Sex differences were consistently documented, but are decreasing in more recent cohorts, who also have higher levels of illegal drug use and extensions in the period of risk for initiation.

          Abstract

          Louisa Degenhardt and colleagues report an international survey of 17 countries that finds clear differences in drug use across different regions of the world.

          Editors' Summary

          Background.

          Understanding how much disability and death a particular disease causes (known as the “burden of disease”) is important. Knowing the burden of a disease in a country contributes to the development of healthier nations by directing strategies and policies against the disease. Researchers' understanding of the burden of diseases across different countries was piecemeal until the 1990 launch of a special World Health Organization (WHO) project, the Global Burden of Disease Project. In 2002, on the basis of updated information from this ongoing project, the WHO estimated that 91 million people were affected by alcohol use disorders and 15 million by drug use disorders.

          Why Was This Study Done?

          It is widely accepted that alcohol, tobacco, and illegal drug use are linked with a considerable amount of illness, disability, and death. However, there are few high-quality data quantifying the amount across different countries, especially in less-developed countries. The researchers therefore set out to collect basic patterns of alcohol, tobacco, cannabis, and cocaine use in different countries. They documented lifetime use of these substances in each county, focusing on young adults. They also wanted to examine the age of onset of use and whether the type of drugs used was affected by one's social and economic status.

          What Did the Researchers Do and Find?

          Data on drug use were available from 54,069 survey participants in 17 countries. The 17 countries were determined by the availability of collaborators and on funding for the survey. Trained lay interviewers carried out face-to-face interviews (except in France where the interviews were done over the telephone) using a standardized, structured diagnostic interview for psychiatric conditions. Participants were asked if they had ever used (a) alcohol, (b) tobacco (cigarettes, cigars or pipes), (c) cannabis (marijuana, hashish), or (d) cocaine. If they had used any of these drugs, they were asked about the age they started using each type of drug. The age of first tobacco smoking was not assessed in New Zealand, Japan, France, Germany, Belgium, The Netherlands, Italy, or Spain. The interviewers also recorded the participants' sex, age, years of education, marital status, employment, and household income.

          The researchers found that in the Americas, Europe, Japan, and New Zealand, alcohol had been used by the vast majority of survey participants, compared to smaller proportions in the Middle East, Africa, and China. The global distribution of drug use is unevenly distributed with the US having the highest levels of both legal and illegal drug use among all countries surveyed. There are differences in both legal and illegal drug use among different socioeconomic groups. For example, males were more likely than females to have used all drug types; younger adults were more likely than older adults to have used all drugs examined; and higher income was related to drug use of all kinds. Marital status was found to be linked only to illegal drug use—the use of cocaine and cannabis is more likely in people who have never been married or were previously married. Drug use does not appear to be related to drug policy, as countries with more stringent policies (e.g., the US) did not have lower levels of illegal drug use than countries with more liberal policies (e.g., The Netherlands).

          What Do These Findings Mean?

          These findings present comprehensive and useful data on the patterns of drug use from national samples representing all regions of the world. The data will add to the understanding of the global burden of disease and should be useful to government and health organizations in developing policies to combat these problems. The study does have its limitations—for example, it surveyed only 17 of the world's countries, within these countries there were different rates of participation, and it is unclear whether people accurately report their drug use when interviewed. Nevertheless, the study did find clear differences in drug use across different regions of the world, with the US having among the highest levels of legal and illegal drug use of all the countries surveyed.

          Additional Information.

          Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0050141.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: not found
          • Book: not found

          Applied Logistic Regression

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

            This paper presents an overview of the World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) and a discussion of the methodological research on which the development of the instrument was based. The WMH-CIDI includes a screening module and 40 sections that focus on diagnoses (22 sections), functioning (four sections), treatment (two sections), risk factors (four sections), socio-demographic correlates (seven sections), and methodological factors (two sections). Innovations compared to earlier versions of the CIDI include expansion of the diagnostic sections, a focus on 12-month as well as lifetime disorders in the same interview, detailed assessment of clinical severity, and inclusion of information on treatment, risk factors, and consequences. A computer-assisted version of the interview is available along with a direct data entry software system that can be used to keypunch responses to the paper-and-pencil version of the interview. Computer programs that generate diagnoses are also available based on both ICD-10 and DSM-IV criteria. Elaborate CD-ROM-based training materials are available to teach interviewers how to administer the interview as well as to teach supervisors how to monitor the quality of data collection.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve

                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                pmed
                plme
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                July 2008
                1 July 2008
                : 5
                : 7
                : e141
                Affiliations
                [1 ] National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia
                [2 ] Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America
                [3 ] Department of Epidemiology, Michigan State University, Lansing, Michigan, United States of America
                [4 ] Department of Psychiatry, University of Leipzig, Leipzig, Germany
                [5 ] Department of Neurosciences and Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
                [6 ] Health Care Research Agency, Bologna, Italy
                [7 ] Department of Psychiatry, University College Hospital, Ibadan, Nigeria
                [8 ] Institute of Mental Health, Peking University, Beijing, China
                [9 ] Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon
                [10 ] Ukrainian Psychiatric Association, Kiev, Ukraine
                [11 ] Hospital Fernand Widal, Paris, France
                [12 ] Department of Epidemiology, National Institute of Psychiatry, Mexico City, Mexico
                [13 ] Braun School of Public Health and Community Medicine, Hebrew University-Hadassah, Jerusalem, Israel
                [14 ] Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands
                [15 ] Sant Joan de Déu- Serveis du Salud Mental (SSM), Barcelona, Spain
                [16 ] Saldarriaga Concha Foundation, Bogotá, Colombia
                [17 ] Department of Psychiatry and Mental Health University of Cape Town, Cape Town, South Africa
                [18 ] National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan
                [19 ] Christchurch School of Medicine and Health Science, Christchurch, New Zealand
                University of Western Sydney, Australia
                Author notes
                * To whom correspondence should be addressed. E-mail: l.degenhardt@ 123456unsw.edu.au
                Article
                07-PLME-RA-0801R2 plme-05-07-02
                10.1371/journal.pmed.0050141
                2443200
                18597549
                f1dd8ac9-3351-4352-b618-09370949c1f5
                Copyright: © 2008 Degenhardt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 26 June 2007
                : 14 May 2008
                Page count
                Pages: 15
                Categories
                Research Article
                Mental Health
                Public Health and Epidemiology
                Substance Use (Including Alcohol)
                Psychiatry
                Public Health
                Epidemiology
                Patients
                Custom metadata
                Degenhardt L, Chiu W-T, Sampson N, Kessler RC, Anthony JC, et al. (2008) Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Med 5(7): e141. doi: 10.1371/journal.pmed.0050141

                Medicine
                Medicine

                Comments

                Comment on this article